|Articles|July 1, 2009
- BioPharm International-07-01-2009
- Volume 22
- Issue 7
BioPharm International, July 2009 (PDF)
An Effective Way to Ensure Consistent Protein Expression
Advertisement
Articles in this issue
over 16 years ago
Moving Toward a Biosimilars Pathway: The Lines are Drawn in Congressover 16 years ago
Biotech Shows Glimmer of an Upward Trendover 16 years ago
Facing Down the Enemyover 16 years ago
Extended Risk Management Proposals Challenge ManufacturersNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
